| ACTH | adrenocorticotropic hormone |
| AIH | autoimmune hepatitis |
| Alb | albumin |
| ALP | alkaline phosphatase |
| ALT | alanine aminotransferase |
| ANA | antinuclear antibody |
| AST | aspartate aminotransferase |
| AUC | area under the curve |
| BMI | body mass index |
| CI | confidence interval |
| CMV | cytomegalovirus |
| CRP | C-reactive protein |
| CTCAE | Common Terminology Criteria for Adverse Events |
| DILI | drug-induced liver injury |
| γ-GTP | gamma-glutamyltransferase |
| ICI | immune checkpoint inhibitor |
| ILD | interstitial lung disease |
| IQR | interquartile range |
| irAE | immune-related adverse event |
| irAE-LI | immune-related liver injury |
| KL-6 | Krebs von den Lungen-6 |
| MMF | mycophenolate mofetil |
| mPSL | methylprednisolone |
| MRCP | magnetic resonance cholangiopancreatography |
| Nivo-Ipi | nivolumab and ipilimumab |
| NLR | neutrophil-to-lymphocyte ratio |
| OR | odds ratio |
| PCR | polymerase chain reaction |
| PD-1 | programmed cell death-1 |
| PSL | prednisolone |
| PT-INR | prothrombin time-international normalized ratio |
| ROC | receiver operating characteristic |
| RUCAM | Roussel Uclaf Causality Assessment Method |
| T-Bil | total bilirubin |
| TSH | thyroid-stimulating hormone |